Xanthatin and xanthinosin from the burs of Xanthium strumarium L. as potential anticancer agents

Canadian Journal of Physiology and Pharmacology

Volumn 85, Issue 11, 2007, Pages 1160-1172

  Ramírez Erosa, Irving ^a   Huang, Yaoge ^a   Hickie, Robert A ^a   Sutherland, Ronald G ^a   Barl, Branka ^a,b  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b Barl and Associates   (Canada)

Author keywords

Asteraceae; Carduus nutans L.; Cytotoxic activity; Echinacea angustifolia DC; Human cancer cell lines; Tanacetum vulgare L.; Xanthatin; Xanthinosin; Xanthium strumarium L.

Indexed keywords

ANTINEOPLASTIC AGENT; CARDUUS NUTANS EXTRACT; CHLOROFORM; ECHINACEA ANGUSTIFOLIA EXTRACT; PLANT EXTRACT; TANACETUM VULGARE EXTRACT; UNCLASSIFIED DRUG; XANTHATIN; XANTHINOSIN; XANTHIUM STRUMARIUM EXTRACT;

ARTICLE; ASTERACEAE; BIOASSAY; BREAST CANCER; CANCER CELL CULTURE; CARDUUS NUTANS; CELL STRAIN; CYTOTOXICITY; ECHINACEA ANGUSTIFOLIA; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; LUNG CANCER; PLANT ROOT; PRIORITY JOURNAL; SCREENING; TANACETUM VULGARE; WILD PLANT; XANTHIUM;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; FURANS; HUMANS; LACTONES; PLANT EXTRACTS; SESQUITERPENES; XANTHIUM;

EID: 38849123228     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/Y07-104     Document Type: Article

References (42)

1. Balandrin, M.F., Klocke, J.A., Wurtele, E.S., and Bollinger, W.H. 1985. Natural plant chemicals: sources of industrial and medicinal materials. Science, 228: 1154-1160. doi:10.1126/science.3890182.
2. Bohlmann, F., Mahanta, P.K., Jakupovic, J., Rastogi, R.C., and Natu, A.A. 1978. New sesquiterpene lactones from Inula species. Phytochemistry, 17: 1165-1172. doi:10.1016/S0031-9422(00)94308-5.
3. Boyd, M.R. 1997. The NCI in vitro anticancer drug discovery screen: concept, implementation, and operation, 1985-1995. In Anticancer drug development guide: preclinical screening, clinical trials, and approval. Edited by B.A. Teicher. Humana Press, Totowa, N.J. pp. 23-42.
4. Cragg, G.M., and Newman, D.J. 1999. Discovery and development of antineoplastic agents from natural sources. Cancer Invest. 17: 153-163.
5. Farnsworth, N.R., and Morris, R.W. 1976. Higher plants - the sleeping giant of drug development. Am. J. Pharm. Sci. Support. Public Health, 148: 46-52.
6. Fiebig, M., Duh, C.-Y., Pezzuto, J.M., Kinghorn, A.D., and Farnsworth, N.R. 1985. Plant anticancer agents, XLI. Cardiac glycosides from Streblus asper. J. Nat. Prod. 48: 981-985.
7. Foster, S. 1991. Echinacea: nature's immune enhancer. Healing Arts Press, Rochester, Vt.
8. Ginesta-Peris, E., Garcia-Breijo, F.J., and Primo-Yúfera, E. 1994. Antimicrobial activity of xanthatin from Xanthium spinosum L. Lett. Appl. Microbiol. 18: 206-208.
9. Graham, J.G., Quinn, M.L., Fabricant, D.S., and Farnsworth, N.R. 2000. Plants used against cancer - an extension of the work of Jonathan Hartwell. J. Ethnopharmacol. 73: 347-377. doi:10.1016/S0378-8741(00)00341-X.
10. Hartwell, J.L. 1968. Plants used against cancer: A survey. Lloydia, 31: 122-158.
11. Hehner, S.P., Heinrich, M., Bork, P.M., Vogt, M., Ratter, F., Lehmann, V., et al. 1998. Sesquiterpene lactones specifically inhibit activation of NF-kappa B by preventing the degradation of I kappa B-alpha and I kappa B-beta. J. Biol. Chem. 273: 1288-1297. doi:10.1074/jbc.273.3.1288.
12. Heinrich, M., Robles, M., West, J.E., Ortiz de Montellano, B.R., and Rodriguez, E. 1998. Ethnopharmacology of Mexican Asteraceae (Compositae). Annu. Rev. Pharmacol. Toxicol. 38: 539-565. doi:10.1146/annurev.pharmtox.38.1. 539.
13. Huang, K.C. 1999. The pharmacology of Chinese herbs. 2nd ed. CRC Press, Boca Raton, Fl.
14. Jackson, S.J., Houghton, P.J., Retsas, S., and Photiou, A. 2000. In vitro cytotoxicity of norviburtinal and isopinnatal from Kigelia pinnata against cancer cell lines. Planta Med. 66: 758-761. doi:10.1055/s-2000- 9778.
15. Johnson, D., Kershaw, L., MacKinnon, A., and Pojar, J. 1995. Plants of the western boreal forest and aspen parkland, Lone Pine Publishing, Edmonton, Alta. pp. 170-191.
16. Jurgens, T.M. 2000. Echinacea. In Herbs: Everyday reference for health professionals. The Canadian Pharmacists Association and the Canadian Medical Association, Ottawa, ON. pp. 102-105.
17. Kim, Y.S., Kim, J.S., Park, S.-H., Choi, S.-U., Lee, C.O., Kim, S.-K., et al. 2003. Two cytotoxic sesquiterpene lactones from the leaves of Xanthium strumarium and their in vitro inhibitory activity on farnesyltransferase. Planta Med. 69: 375-377. doi:10.1055/s-2003-38879.
18. Kingston, D.G.I. 1993. Taxol, an exciting anticancer drug from Taxus brevifolia: an overview. In Human medicinal agents from plants. Edited by A.D. Kinghorn, and M.F. Balandrin. Symposium Series 534. American Chemical Society, Washington, D.C. pp. 138-148.
19. Lavault, M., Landreau, A., Larcher, G., Bouchara, J.-P., Pagniez, F., Le Pape, P., and Richomme, P. 2005. Antileishmanial and antifungal activities of xanthanolides isolated from Xanthium macrocarpum. Fitoterapia, 76: 363-366. doi:10.1016/j.fitote.2005.03.019.
20. Marco, J.A., Sanz-Cervera, J.F., Corral, J., Carda, M., and Jakupovic, J. 1993. Xanthanolides from Xanthium: absolute configuration of xanthanol, isoxanthanol and their C-4 epimers. Phytochemistry, 34: 1569-1576. doi:10.1016/S0031-9422(00)90847-1.
21. McMillan, C., Chavez, P.I., and Mabry, T.J. 1975a. Sesquiterpene lactones of Xanthium strumarium in a Texas population and in experimental hybrids. Biochem. Syst. Ecol. 3: 137-141.
22. McMillan, C., Chavez, P.I., Plettman, S.G., and Mabry, T.J. 1975b. Systematic implications of the sesquiterpene lactones in the "strumarium" morphological complex (Xanthium strumarium, Asteraceae) of Europe, Asia and Africa. Biochem. Syst. Ecol. 2: 181-184.
23. Meyer, H.J., and van Staden, J. 1989. Geigeria aspera Harv.: in vitro culture and medicinal value of sesquiterpene lactones. In Medicinal and aromatic plants II. Biotechnology in agriculture and forestry. Vol. 7. Edited by Y.P.S. Bajaj. Springer-Verlag, Berlin. pp. 227-245.
24. McCutcheon, A.R., Ellis, S.M., Hancock, R.E., and Towers, G.H. 1992. Antibiotic screening of medicinal plants of the British Columbian native peoples. J. Ethnopharmacol. 37: 213-223. doi:10.1016/0378-8741(92)90036- Q.
25. Newall, C.A., Anderson, L.A., and Phillipson, J.D. 1996. Herbal medicines: a guide for health-care professionals. The Pharmaceutical Press, London, U.K.
26. Newman, D.J., Cragg, G.M., and Snader, K.M. 2003. Natural products as sources of new drugs over the period 1981-2002. J. Nat. Prod. 66: 1022-1037. doi:10.1021/np030096l.
27. Pagé, M. 1997. High-volume screening. In Anticancer drug development guide. preclinical screening, clinical trials, and approval, Part I. In vitro methods. Edited by B.A. Teicher. Human Press, Totowa, NJ. pp. 3-21.
28. Pelletier, W.S., Chokshi, H.P., and Desai, H.K. 1986. Separation of diterpenoid alkaloid mixtures using vacuum liquid chromatography. J. Nat. Prod. 49: 892-900. doi:10.1021/np50047a021.
29. Pettit, G.R. 1995. The scientific contributions of Jonathan L. Hartwell Ph.D. J. Nat. Prod. 58: 359-364. doi:10.1021/np50117a003.
30. Pojar, J., and MacKinnon, A. 1994. Plants of the Pacific northwest coast; Washington, Oregon, British Columbia, and Alaska. Lone Pine Publishing, Redmond, Wash.
31. Promega Corporation. 1999. CellTiter 96® non-radioactive cell proliferation assay. Technical Bulletin No. 112. Promega Corp., Madison, Wis. pp. 1-13.
32. Robbers, J.E., and Tyler, V.E. 1999. Tyler's herbs of choice: the therapeutic use of phytomedicinals. The Haworth Herbal Press, NY. 287.
33. Ross, I.A. 2001. Echinacea angustifolia L. In Medicinal plants of the world: chemical constituents, traditional and modern uses. Vol. 2. Humana Press, Inc., Totowa, N.J.
34. Ross, J.J., Arnason, J.T., and Birnboim, H.C. 1999. Low concentrations of the feverfew component parthenolide inhibit in vitro growth of tumor lines in a cytostatic fashion. Planta Med. 65: 126-129. doi:10.1055/s-1999-13972.
35. Roussakis, C., Chinou, I., Vayas, C., Harvala, C., and Verbist, J.F. 1994. Cytotoxic activity of xanthatin and the crude extracts of Xanthium strumarium. Planta Med. 60: 473-474. doi:10.1055/s-2006-959537.
36. Shemluck, M. 1982. Medicinal and other uses of the Compositae by Indians in the United States and Canada. J. Ethnopharmacol. 5: 303-358. doi:10.1016/0378-8741(82)90016-2.
37. Shylesh, B.S., and Padikkala, J. 2000. In vitro cytotoxic and antitumor property of Emilia sonchifolia (L.) DC in mice. J. Ethnopharmacol. 73: 495-500. doi:10.1016/S0378-8741(00)00317-2.
38. 50-values and cell survival. Eur. J. Clin. Chem. Clin. Biochem. 33: 813-823.
39. Sneden, A.T. 1984. Novel antitumor agents from plants. In Anticancer and interferon agents: synthesis and properties (drugs and the pharmaceutical sciences: a series of textbooks and monographs). Edited by R.M. Ottenbrite and G.B. Butler. Marcel Dekker Inc., New York, NY. pp. 80-111.
40. Tang, W., and Eisenbrand, W.G. 1992. Chinese drugs of plant origin: chemistry, pharmacology, and use in traditional and modern medicine, Springer-Verlag, Berlin.
41. Ukiya, M., Akihisa, T., Tokuda, H., Suzuki, H., Mukainaka, T., Ichiishi, E., et al. 2002. Constituents of Compositae plants III: Anti-tumor promoting effects and cytotoxic activity against human cancer cell lines of triterpene diols and triols from edible chrysanthemum flowers. Cancer Lett. 177: 7-12. doi:10.1016/S0304-3835(01)00769-8.
42. Wagner, H., and Bladt, S. 1984. Plant drug analysis: a thin layer chromatography atlas. Springer-Verlag, Berlin, Germany.